Cargando…
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
PURPOSE: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion. METHODS: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema...
Autores principales: | Udaondo, Patricia, Garcia-Delpech, Salvador, Salom, David, Garcia-Pous, Maria, Diaz-Llopis, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141857/ https://www.ncbi.nlm.nih.gov/pubmed/21792283 http://dx.doi.org/10.2147/OPTH.S18873 |
Ejemplares similares
-
Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
por: Udaondo, Patricia, et al.
Publicado: (2011) -
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
por: Kiire, Christine A, et al.
Publicado: (2015) -
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
por: Yoo, Seul Gi, et al.
Publicado: (2015) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008) -
Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Lee, Kyou Ho, et al.
Publicado: (2017)